APA (7th ed.) Citation

Soyka, M., Backmund, M., Schmidt, P., & Apelt, S. (2014). Buprenorphine-naloxone treatment in opioid dependence and risk of liver enzyme elevation: Results from a 12-month observational study. American Journal on Addictions, 23(6), 563. https://doi.org/10.1111/j.1521-0391.2014.12131.x

Chicago Style (17th ed.) Citation

Soyka, Michael, Markus Backmund, Peggy Schmidt, and Sabine Apelt. "Buprenorphine-naloxone Treatment in Opioid Dependence and Risk of Liver Enzyme Elevation: Results from a 12-month Observational Study." American Journal on Addictions 23, no. 6 (2014): 563. https://doi.org/10.1111/j.1521-0391.2014.12131.x.

MLA (9th ed.) Citation

Soyka, Michael, et al. "Buprenorphine-naloxone Treatment in Opioid Dependence and Risk of Liver Enzyme Elevation: Results from a 12-month Observational Study." American Journal on Addictions, vol. 23, no. 6, 2014, p. 563, https://doi.org/10.1111/j.1521-0391.2014.12131.x.